| PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas (NCT05190172) | Oslo University Hospital | 2022-01-14 |
| A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery (NCT04702581) | Hospices Civils de Lyon | 2021-12-07 |
| Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models (NCT04970615) | Sümeyye Sezer | 2021-05-15 |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). (NCT05331521) | University Hospital Heidelberg | 2021-04-07 |
| Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082) | Jazz Pharmaceuticals | 2020-10-26 |
| Proteomic Characterization of Aggressive Oligodendrogliomas (NCT04843085) | Hospices Civils de Lyon | 2020-09-30 |
| Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma (NCT04105374) | NRG Oncology | 2020-01-31 |
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas (NCT04623931) | M.D. Anderson Cancer Center | 2020-01-30 |
| Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma (NCT03014804) | Jonsson Comprehensive Cancer Center | 2019-12-01 |
| Social Determinants of Health in Glioblastoma Population (NCT03900689) | Wake Forest University Health Sciences | 2019-05-22 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma (NCT03180502) | NRG Oncology | 2018-01-23 |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology (NCT04648462) | Maastricht Radiation Oncology | 2018-01-01 |
| NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma (NCT03353896) | University of Southern California | 2017-12-15 |
| A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 (NCT03152318) | Dana-Farber Cancer Institute | 2017-07-18 |
| A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) (NCT02924038) | Nicholas Butowski | 2017-04-03 |
| GliomaAI-Oligo: MRI-Based Detection of IDH Mutant Oligodendroglioma (NCT07673705) | Deep Learning Institute of Radiological Sciences | 2017-03-14 |
| RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas (NCT02871843) | EpicentRx, Inc. | 2017-02-14 |
| Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas (NCT02976441) | Washington University School of Medicine | 2017-01-01 |
| Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma (NCT02549833) | Jennie Taylor | 2016-10-17 |
| First in Patient Study for PF-06840003 in Malignant Gliomas (NCT02764151) | Pfizer | 2016-09-09 |
| Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors (NCT02747407) | Wake Forest University Health Sciences | 2016-05-01 |
| Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved (NCT02530320) | Grupo Español de Investigación en Neurooncología | 2015-10-25 |
| Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors (NCT02372409) | Washington University School of Medicine | 2015-08-14 |
| A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas (NCT02209428) | Huashan Hospital | 2014-06-01 |
| Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas (NCT01849952) | Dartmouth-Hitchcock Medical Center | 2013-10-09 |
| Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors (NCT01836549) | Pediatric Brain Tumor Consortium | 2013-03-01 |
| Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma (NCT01649830) | Sun Yat-sen University | 2012-07-01 |
| Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors (NCT01609790) | National Cancer Institute (NCI) | 2012-06-04 |
| HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas (NCT00874861) | Ian F. Pollack, M.D. | 2009-04-01 |
| A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma (NCT00683761) | TransMolecular | 2008-08-01 |
| FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma (NCT01089244) | Ludwig-Maximilians - University of Munich | 2008-06-01 |
| Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma (NCT00591058) | TransMolecular | 2008-02-01 |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma (NCT00389090) | Keryx / AOI Pharmaceuticals, Inc. | 2006-10-01 |
| Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma (NCT00575887) | Marmara University | 2006-08-01 |
| The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) (NCT00392171) | Merck Sharp & Dohme LLC | 2006-06-09 |
| Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas (NCT00360828) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols (NCT00035373) | National Cancer Institute (NCI) | 2002-04-19 |
| Genetic Analysis of Brain Tumors (NCT00031538) | National Cancer Institute (NCI) | 2002-03-01 |
| Prolonged Daily Temozolomide for Low-Grade Glioma (NCT00165360) | Dana-Farber Cancer Institute | 2001-09-01 |
| Natural History of Patients With Brain and Spinal Cord Tumors (NCT00009035) | National Cancer Institute (NCI) | 2001-01-22 |
| Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide (NCT00717210) | Neuro-Oncology Working Group of the German Cancer Society | 1999-06-01 |
| A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas (NCT00080054) | Pharmacyclics LLC. | |